Structured population-based prostate-specific antigen screening for prostate cancer: the European Association of Urology position in 2019

G Gandaglia, P Albers, PA Abrahamsson, A Briganti… - European urology, 2019 - Elsevier
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …
被引用次数：122 相关文章

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.

G Gandaglia, P Albers, PA Abrahamsson… - European …, 2019 - europepmc.org
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55-69yr) using prostate-specific antigen (PSA) is …

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - European …, 2019 - lup.lub.lu.se
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - … : Official Journal of the …, 2019 - repub.eur.nl
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - EUROPEAN …, 2019 - iris.unisr.it
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …
[PDF] researchgate.net

[PDF][PDF] Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - EUROPEAN …, 2019 - researchgate.net
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - European …, 2019 - research.regionh.dk
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55-69yr) using prostate-specific antigen (PSA) is …

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - European …, 2019 - portal.research.lu.se
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …
[PDF] europa-uomo.org

[PDF][PDF] Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - EUROPEAN …, 2019 - europa-uomo.org
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019

G Gandaglia, P Albers, PA Abrahamsson… - European …, 2019 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55-69yr) using prostate-specific antigen (PSA) is …